Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Associated Pulmonary Arterial Hypertension”

138 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 138 results

Testing effectiveness (Phase 2)Looking for participantsNCT07175038
What this trial is testing

ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Hypertension, Interstitial Lung Disease
AllRock Bio, Inc. 40
Testing effectiveness (Phase 2)Ended earlyNCT04053543
What this trial is testing

CXA-10 Study in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
PAH
Complexa, Inc. 33
Large-scale testing (Phase 3)Ended earlyNCT03267108
What this trial is testing

Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon Pulse Technologies 145
Testing effectiveness (Phase 2)Study completedNCT01728220
What this trial is testing

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary Disease
Bellerophon Pulse Technologies 159
Not applicableUnknownNCT01397110
What this trial is testing

Respiratory and Physical Therapy in Patients With Associated Pulmonary Arterial Hypertension (APAH) With Congenital Heart Defects

Who this might be right for
Pulmonary Arterial HypertensionEisenmenger Syndrome
Heidelberg University 50
Not applicableNot Yet RecruitingNCT07214376
What this trial is testing

Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

Who this might be right for
Pulmonary HypertensionHeart Failure With Reduced Ejection FractionHypertension+5 more
Pulnovo Medical, Inc. 750
Not applicableStudy completedNCT05703802
What this trial is testing

Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.

Who this might be right for
SepsisPre-EclampsiaGranulomatosis With Polyangiitis+4 more
University Hospital Muenster 30
Not applicableUnknownNCT02850692
What this trial is testing

Portal Hypertension and Systemic Endothelial Function

Who this might be right for
Cystic FibrosisPortal Hypertension
Hopital Foch 60
Early research (Phase 1)Study completedNCT00240656
What this trial is testing

Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, Pulmonary
Hebei Medical University
Not applicableStudy completedNCT02267200
What this trial is testing

The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHD

Who this might be right for
Hypertension,Pulmonary
Shanghai Jiao Tong University School of Medicine 30
Not applicableLooking for participantsNCT07236970
What this trial is testing

Multicenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligence for Patients With Systemic Sclerosis

Who this might be right for
Pulmonary HypertensionSystemic Sclerosis (SSc)Systemic Sclerosis-Associated PAH
Alejandro Cruz Utrilla 350
Testing effectiveness (Phase 2)Ended earlyNCT01065051
What this trial is testing

Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics

Who this might be right for
Hypertension, PulmonaryVentricular Dysfunction, Left
Bayer 1
Not applicableUnknownNCT02777957
What this trial is testing

Predictors of Pulmonary Hypertension in Patients With Advanced Lung Diseases

Who this might be right for
Pulmonary Hypertension
Silesian Centre for Heart Diseases 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07285655
What this trial is testing

Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

Who this might be right for
Pulmonary Hypertension Due to Lung Disease (Disorder)
Liquidia Technologies, Inc. 344
Large-scale testing (Phase 3)Ended earlyNCT03037580
What this trial is testing

Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction

Who this might be right for
Pulmonary HypertensionHeart Failure With Preserved Ejection Fraction
United Therapeutics 84
Testing effectiveness (Phase 2)Study completedNCT01862536
What this trial is testing

Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary Disease (COPD)
VA Office of Research and Development 44
Large-scale testing (Phase 3)Study completedNCT00581607
What this trial is testing

Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension

Who this might be right for
SarcoidosisPulmonary Arterial Hypertension
University of Cincinnati 43
Early research (Phase 1)Study completedNCT04370873
What this trial is testing

Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006)

Who this might be right for
Pulmonary Hypertension
Merck Sharp & Dohme LLC 22
Testing effectiveness (Phase 2)Looking for participantsNCT06635850
What this trial is testing

Mosliciguat in PH-ILD

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseLung Diseases+3 more
Pulmovant, Inc. 120
Not applicableUnknownNCT06172790
What this trial is testing

The Effects of the Otago Exercise Program

Who this might be right for
Pulmonary Arterial HypertensionHeart Defects, Congenital
Istanbul University - Cerrahpasa 50
Load More Results